GE HealthCare’s first quarter results surpassed Wall Street’s revenue and non-GAAP profit expectations, buoyed by robust ...

Assessing the distribution of a medication in the brain is critical for the treatment of a vast range of neurological ...

Compatible with GEHC’s Omni Legend PET/CT and other systems, the agent is designed to support detailed assessment of myocardial perfusion, ischemia, and infiltrative cardiomyopathies.

GE HealthCare GEHC recently unveiled new advancements in precision cardiac care at the 2025 SNMMI annual meeting in New Orleans, with a spotlight on Flyrcado—its FDA-approved Positron Emission ...

GE HealthCare GEHC recently unveiled new advancements in precision cardiac care at the 2025 SNMMI annual meeting in New Orleans, with a spotlight on Flyrcado—its FDA-approved Positron Emission ...

Stanford (Calif.) Medicine has renewed its research partnership with GE HealthCare to develop new clinical pathways and imaging solutions through the use of total-body PET/CT. Through their ...

GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body positron emission tomography/computed tomography (PET/CT) technology for new clinical pathways to help ...

Knowing the potential of this technology, researchers at Stanford Medicine and engineers at GE HealthCare aim to advance a next-generation PET/CT designed to provide new opportunities to improve ...

CHICAGO, June 19, 2025--Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentions ...

CHICAGO-- (BUSINESS WIRE)--Jun 19, 2025--Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine ...

CHICAGO-- (BUSINESS WIRE)--Jun 19, 2025--Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine ...